Since 1967, we have been innovating to support scientific and technological progress in the service of diagnosis, prevention and precision medicine for all.
Alongside associations and its public and institutional partners, the Cerba Institute is mobilizing to support patients, health professionals and research teams.
Cerba Research and ACT Genomics announce strategic joint venture — CerbACT Asia
News
19 August 2021
A quarter of severe forms of Covid-19 can be explained by a genetic or immunological abnormality
Press release
22 July 2021
Cerba HealthCare pursues its growth strategy with the acquisition of Lifebrain in Italy
Press release
19 July 2021
METAFORA biosystems, l’AP-HP ET Cerba HealthCare ont présenté les résultats de l’étude de validation du test METAglut1 lors du 3ème congrès européen sur le syndrome de deficit en Glut1.
Press release
21 June 2021
Covid-19: Laboratoire Cerba ready to sequence on a larger scale
Press release
28 May 2021
IFC, Proparco, and Cerba Lancet Africa partner to Expand Diagnostic Capacity, Support COVID-19 Response in Africa
Press release
30 March 2021
Cerba HealthCare welcomes EQT Group as new shareholder to foster innovation and better respond to new health issues
News
26 March 2021
The development of employees, a strong marker of our Group
Press release
24 March 2021
COVID-19: Cerba HealthCare launches new quantitative COVID-19 serology test